Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.

enGene Holdings Inc has a consensus price target of $24.58 based on the ratings of 12 analysts. The high is $34 issued by Guggenheim on April 15, 2024. The low is $10 issued by UBS on November 12, 2025. The 3 most-recent analyst ratings were released by Morgan Stanley, Oppenheimer, and UBS on November 12, 2025, respectively. With an average price target of $20.67 between Morgan Stanley, Oppenheimer, and UBS, there's an implied 145.16% upside for enGene Holdings Inc from these most-recent analyst ratings.
1calculated from analyst ratings
| Get Alert | |||||
|---|---|---|---|---|---|
| Nov 12, 2025 | 125.39% | 1819 | Previous Overweight Current Overweight | Get Alert | |
| Nov 12, 2025 | 291.46% | 3033 | Previous Outperform Current Outperform | Get Alert | |
| Nov 12, 2025 | 18.62% | 410 | Previous Neutral Current Neutral | Get Alert | |
| Nov 12, 2025 | 149.11% | 1821 | Previous Market Outperform Current Market Outperform | Get Alert | |
| Sep 12, 2025 | 113.52% | 1819 | Previous Overweight Current Overweight | Get Alert | |
| Sep 12, 2025 | 196.56% | 2525 | Previous Buy Current Buy | Get Alert | |
| Sep 8, 2025 | 196.56% | 2525 | Previous Buy Current Buy | Get Alert | |
| Apr 29, 2025 | 113.52% | 1818 | Previous Market Outperform Current Market Outperform | Get Alert | |
| Mar 11, 2025 | 303.32% | 3437 | Previous Overweight Current Overweight | Get Alert | |
| Mar 11, 2025 | 196.56% | 2525 | Previous Buy Current Buy | Get Alert | |
| Feb 18, 2025 | 208.42% | 26 | Previous Initiates Current Overweight | Get Alert | |
| Feb 14, 2025 | -16.96% | 734 | Previous Buy Current Neutral | Get Alert | |
| Dec 23, 2024 | 113.52% | 1818 | Previous Market Outperform Current Market Outperform | Get Alert | |
| Dec 23, 2024 | 196.56% | 25 | Previous Initiates Current Buy | Get Alert | |
| Dec 6, 2024 | 113.52% | 1818 | Previous Market Outperform Current Market Outperform | Get Alert | |
| Nov 27, 2024 | 172.84% | 23 | Previous Initiates Current Outperform | Get Alert | |
| Nov 18, 2024 | 113.52% | 18 | Previous Initiates Current Market Outperform | Get Alert | |
| Sep 24, 2024 | 255.87% | 3030 | Previous Outperform Current Outperform | Get Alert | |
| Sep 11, 2024 | 374.5% | 4040 | Previous Overweight Current Overweight | Get Alert | |
| Aug 28, 2024 | 255.87% | 30 | Previous Initiates Current Outperform | Get Alert | |
| Apr 22, 2024 | 255.87% | 30 | Previous Initiates Current Overweight | Get Alert | |
| Apr 15, 2024 | 303.32% | 34 | Previous Initiates Current Buy | Get Alert | |
| Mar 28, 2024 | 338.91% | 37 | Previous Initiates Current Buy | Get Alert | |
| Mar 8, 2024 | 374.5% | 40 | Previous Initiates Current Overweight | Get Alert | |
| Feb 20, 2024 | 267.73% | 31 | Previous Initiates Current Outperform | Get Alert |
The latest price target for enGene Holdings (NASDAQ:ENGN) was reported by Morgan Stanley on November 12, 2025. The analyst firm set a price target for $19.00 expecting ENGN to rise to within 12 months (a possible 125.39% upside). 14 analyst firms have reported ratings in the last year.
The latest analyst rating for enGene Holdings (NASDAQ:ENGN) was provided by Morgan Stanley, and enGene Holdings maintained their overweight rating.
There is no last upgrade for enGene Holdings
The last downgrade for enGene Holdings Inc happened on February 14, 2025 when UBS changed their price target from $34 to $7 for enGene Holdings Inc.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of enGene Holdings, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for enGene Holdings was filed on November 12, 2025 so you should expect the next rating to be made available sometime around November 12, 2026.
While ratings are subjective and will change, the latest enGene Holdings (ENGN) rating was a maintained with a price target of $18.00 to $19.00. The current price enGene Holdings (ENGN) is trading at is $8.43, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.